NHO Hiroshimanishi Medical Center

Hiroshima 739-0696

1 studies enrolling now · 2 studies all time

What they study most

Alzheimer Disease, End Stage Kidney Disease

Studies at this site

• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease — Running, not enrolling